8.3.2001 Official Journal of the European Communities L 66/39 COMMISSION DECISION of 22 February 2001 amending Annex I to Council Decision 91/666/EEC establishing Community reserves of foot-and- mouth disease vaccines and updating Decision 2000/112/EC with regard to distribution between antigen banks of antigen reserves (notified under document number C(2001) 425) (Text with EEA relevance) (2001/181/EC) THE COMMISSION OF THE EUROPEAN COMMUNITIES, Having regard to the Treaty establishing the European Community, Having regard to Council Decision 91/666/EEC of 11 December 1991 establishing Community reserves of foot-and- mouth disease vaccines ('), as last amended by Decision 1999/ 762[EC (3, and in particular Articles 7 and 9 thereof, Having regard to Council Decision 90/424[EEC of 26 June 1990 on expenditure in the veterinary field (%), as last amended by Regulation (EC) No 1258/1999 (%), and in particular Article 14 thereof, Whereas: 1) In conformity with Decision 91/666/EEC, the purchase of antigens is a part of the Community action to estab- lish Community reserves of foot-and-mouth disease vaccines. Annex [ to Decision 91/666/EEC details the quantities and subtypes of antigen of the foot-and-mouth disease virus to be stored in Community antigen reserves. Forced by the epidemiological situation and following the advice of the World Reference Laboratory for Foot-and-Mouth Disease, Pirbright, United Kingdom, and the advice of an expert group established to review certain provisions of Directive 85/511/EEC (%), as last amended by the Act of Accession of Austria, Finland and Sweden, the Community has made purchases of subtypes and quantities of foot-and-mouth disease virus antigens. By Commission Decision 93/590/EC of 5 November 1993 for the purchase by the Community of foot-and- mouth disease antigens within the framework of the Community action concerning reserves of foot-and- mouth disease vaccines (%), as last amended by Decision 2000/112/EC ('), arrangements were made for purchase of A5, A22 and O1 foot-and-mouth disease virus antigens. 368, 31.12.1991, p. 21. 301, 24.11.1999, p. 6. 224, 18.8.1990, p. 19. 315, 26.11.1985, p. 11. 280, 13.11.1993, p. 33. 33, 8.2.2000, p. 21. ) o L (3 o] L () O] L () O] L 160, 26.6.1999, p. 103. () O] L () O] L () O] L () (10) By Commission Decision 97/348/EC of 23 May 1997 for the purchase by the Community of foot-and-mouth disease antigens and for the formulation, production, bottling and distribution of vaccines against foot-and- mouth disease (%), as last amended by Decision 2000/ 112/EC, arrangements were made for the purchase of A22-Irag, C1 and ASIA1 foot-and-mouth disease virus antigens. By Commission Decision 2000/77/EC of 17 December 1999 for the purchase by the Community of foot-and- mouth disease antigens and for the formulation, produc- tion, bottling and distribution of vaccines against foot-and-mouth disease (°), arrangements were made for purchase of certain quantities of A Iran 96, A Iran 99, A Malaysia 97, SAT 1, SAT 2 (East African and Southern African strains) and SAT 3 foot-and-mouth disease virus antigen. By Commission Decision 2000/569/EC of 8 September 2000 for the purchase by the Community of foot-and- mouth disease antigens and for the formulation, produc- tion, bottling and distribution of vaccines against foot-and-mouth disease ('%), arrangements were made for purchase of additional quantities of A22-Iraq, O1-Manisa, ASIA 1-Shamir, A Malaysia 97, SAT 1, SAT 2 (East African and Southern African strains) and SAT 3 foot-and-mouth disease virus antigen. It appears necessary to align Annex I to Decision 91/ 666/EEC to the purchases made by the Community in the light of the epidemiological development. It appears also appropriate to update the Annex to Decision 2000/112/EC  detailing the distribution between antigen banks of antigen reserves established within the framework of the Community action concerning reserves of foot-and-mouth disease vaccines and amending Decisions 93/590/EC and 97/348/EC. The measures provided for in this Decision are in accordance with the opinion of the Standing Veterinary Commiittee, (% O) L 148, 6.6.1997, p. 27. () O] L 30, 4.2.2000, p. 35. (%) O] L 238, 22.9.2000, p. 61.